SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Mark C. H. Groot, Gianmario Candore, Md. Jamal Uddin, Patrick C. Souverein, M. Sanni Ali, Svetlana V. Belitser, Consuelo Huerta, Rolf H. H. Groenwold, Yolanda Alvarez, Jim Slattery, Joke Korevaar, Arno W. Hoes, Kit C. B. Roes, Anthonius Boer, Ian J. Douglas, Raymond G. Schlienger, Robert Reynolds, Olaf H. Klungel, Helga Gardarsdottir, Case-only designs for studying the association of antidepressants and hip or femur fracture, Pharmacoepidemiology and Drug Safety, 2016, 25,
  2. You have free access to this content2
    Gema Requena, John Logie, Elisa Martin, Nada Boudiaf, Rocío González González, Consuelo Huerta, Arturo Alvarez, David Webb, Andrew Bate, Luis A. García Rodríguez, Robert Reynolds, Raymond Schlienger, Helga Gardarsdottir, Mark Groot, Olaf H. Klungel, Fancisco Abajo, Ian J. Douglas, Do case-only designs yield consistent results across design and different databases? A case study of hip fractures and benzodiazepines, Pharmacoepidemiology and Drug Safety, 2016, 25,
  3. 3
    Peter Tugwell, J. André Knottnerus, Extrapolating results from adult trials to children, Journal of Clinical Epidemiology, 2016, 71, 1

    CrossRef

  4. 4
    Koen Bernardus Pouwels, Bianca Mulder, Eelko Hak, Moderate concordance was found between case-only and parallel group designs in systematic comparison, Journal of Clinical Epidemiology, 2016, 71, 18

    CrossRef

  5. 5
    S Hennessy, CE Leonard, JJ Gagne, JH Flory, X Han, CM Brensinger, WB Bilker, Pharmacoepidemiologic Methods for Studying the Health Effects of Drug–Drug Interactions, Clinical Pharmacology & Therapeutics, 2016, 99, 1
  6. 6
    Nathalie Gault, Johann Castañeda-Sanabria, Sylvie Guillo, Stéphanie Foulon, Florence Tubach, Underuse of self-controlled designs in pharmacoepidemiology in electronic healthcare databases: a systematic review, Pharmacoepidemiology and Drug Safety, 2016, 25, 4
  7. 7
    Chris Fook Sheng Ng, Yutaka Matsuyama, Yasuo Ohashi, Case-Only Method to Estimate the Relative Incidence of Adverse Events for Comparison of Two Treatments: Application in Disseminated Intravascular Coagulation Patients, Japanese Journal of Biometrics, 2015, 36, 1, 13

    CrossRef

  8. 8
    Sean Hennessy, Charles E. Leonard, Comment on: “Desideratum for Evidence-Based Epidemiology”, Drug Safety, 2015, 38, 1, 101

    CrossRef

  9. 9
    Donald A. Redelmeier, Deva Thiruchelvam, Andrew J. Lustig, Cross-linked survey analysis is an approach for separating cause and effect in survey research, Journal of Clinical Epidemiology, 2015, 68, 1, 35

    CrossRef

  10. 10
    Chia-Hsuin Chang, Jou-Wei Lin, Chin-Hsien Lin, Hsi-Chieh Chen, Juey-Jen Hwang, Mei-Shu Lai, Effectiveness and safety of extracranial carotid stent placement: A nationwide self-controlled case-series study, Journal of the Formosan Medical Association, 2015, 114, 3, 274

    CrossRef

  11. 11
    Inger Johanne Bakken, Kari Modalsli Aaberg, Sara Ghaderi, Nina Gunnes, Lill Trogstad, Per Magnus, Siri Eldevik Håberg, Febrile seizures after 2009 influenza A (H1N1) vaccination and infection: a nationwide registry-based study, BMC Infectious Diseases, 2015, 15, 1

    CrossRef

  12. 12
    Silvia Pérez-Vilar, Javier Díez-Domingo, Joan Puig-Barberà, Ruth Gil-Prieto, Silvana Romio, Intussusception following rotavirus vaccination in the Valencia Region, Spain, Human Vaccines & Immunotherapeutics, 2015, 11, 7, 1848

    CrossRef

  13. 13
    Michael J. Leach, Nicole L. Pratt, Elizabeth E. Roughead, Psychoactive medicine use and the risk of hip fracture in older people: a case-crossover study, Pharmacoepidemiology and Drug Safety, 2015, 24, 6
  14. 14
    S. V. Wang, S. Schneeweiss, M. Maclure, J. J. Gagne, "First-Wave" Bias When Conducting Active Safety Monitoring of Newly Marketed Medications with Outcome-Indexed Self-Controlled Designs, American Journal of Epidemiology, 2014, 180, 6, 636

    CrossRef

  15. 15
    Hanae Ueyama, Shiro Hinotsu, Shiro Tanaka, Hisashi Urushihara, Masaki Nakamura, Yuji Nakamura, Koji Kawakami, Application of a Self-Controlled Case Series Study to a Database Study in Children, Drug Safety, 2014, 37, 4, 259

    CrossRef

  16. 16
    S. Doerken, M. Mockenhaupt, M. Schumacher, P. Sekula, Assessment of the "Case-Chaos" Design as an Adjunct to the Case-Control Design, American Journal of Epidemiology, 2014, 179, 6, 775

    CrossRef

  17. 17
    Malcolm Maclure, Case–Crossover Designs for More Patient-Centred Epidemiology, Paediatric and Perinatal Epidemiology, 2014, 28, 2
  18. 18
    Koen B. Pouwels, Gerard A. Kalkman, Daan Schagen, Sipke T. Visser, Eelko Hak, Is combined use of SSRIs and NSAIDs associated with an increased risk of starting peptic ulcer treatment?, British Journal of Clinical Pharmacology, 2014, 78, 1
  19. 19
    J. Hallas, A. Pottegård, Use of self-controlled designs in pharmacoepidemiology, Journal of Internal Medicine, 2014, 275, 6
  20. 20
    Patrick B. Ryan, Paul E. Stang, J. Marc Overhage, Marc A. Suchard, Abraham G. Hartzema, William DuMouchel, Christian G. Reich, Martijn J. Schuemie, David Madigan, A Comparison of the Empirical Performance of Methods for a Risk Identification System, Drug Safety, 2013, 36, S1, 143

    CrossRef

  21. 21
    Xiaofeng Zhou, Sundaresan Murugesan, Harshvinder Bhullar, Qing Liu, Bing Cai, Chuck Wentworth, Andrew Bate, An Evaluation of the THIN Database in the OMOP Common Data Model for Active Drug Safety Surveillance, Drug Safety, 2013, 36, 2, 119

    CrossRef

  22. 22
    Joel Monárrez-Espino, Jette Möller, Hans-Yngve Berg, Majid Kalani, Lucie Laflamme, Analgesics and road traffic crashes in senior drivers: An epidemiological review and explorative meta-analysis on opioids, Accident Analysis & Prevention, 2013, 57, 157

    CrossRef

  23. 23
    Koen B. Pouwels, Sipke T. Visser, H. Jens Bos, Eelko Hak, Angiotensin-Converting Enzyme Inhibitor Treatment and the Development of Urinary Tract Infections: A Prescription Sequence Symmetry Analysis, Drug Safety, 2013, 36, 11, 1079

    CrossRef

  24. 24
    Giulia P. Consiglio, Andrea M. Burden, Malcolm Maclure, Lisa McCarthy, Suzanne M. Cadarette, Case-crossover study design in pharmacoepidemiology: systematic review and recommendations, Pharmacoepidemiology and Drug Safety, 2013, 22, 11
  25. 25
    Caitlin N. Dodd, Silvana A. Romio, Steven Black, Claudia Vellozzi, Nick Andrews, Miriam Sturkenboom, Patrick Zuber, Wei Hua, Jan Bonhoeffer, Jim Buttery, Nigel Crawford, Genevieve Deceuninck, Corinne de Vries, Philippe De Wals, M. Victoria Gutierrez- Gimeno, Harald Heijbel, Hayley Hughes, Kwan Hur, Anders Hviid, Jeffrey Kelman, Tehri Kilpi, S.K. Chuang, Kristine Macartney, Melisa Rett, Vesta Richardson Lopez-Callada, Daniel Salmon, Francisco Gimenez Sanchez, Nuria Sanz, Barbara Silverman, Jann Storsaeter, Umapathi Thirugnanam, Nicoline van der Maas, Katherine Yih, Tao Zhang, Hector Izurieta, International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines, Vaccine, 2013, 31, 40, 4448

    CrossRef

  26. 26
    Patrick Ryan, Marc A. Suchard, Martijn Schuemie, David Madigan, Learning From Epidemiology: Interpreting Observational Database Studies for the Effects of Medical Products, Statistics in Biopharmaceutical Research, 2013, 5, 3, 170

    CrossRef

  27. 27
    Nicole Pratt, Morten Andersen, Ulf Bergman, Nam-Kyong Choi, Tobias Gerhard, Cecilia Huang, Michio Kimura, Tomomi Kimura, Kiyoshi Kubota, Edward Chia-Cheng Lai, Nobuhiro Ooba, Urban Ösby, Byung-Joo Park, Tsugumichi Sato, Ju-Young Shin, Anders Sundström, Yea-Huei Kao Yang, Elizabeth E Roughead, Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study, Pharmacoepidemiology and Drug Safety, 2013, 22, 9
  28. 28
    C. Quantin, E. Benzenine, M. Velten, F. Huet, C. P. Farrington, P. Tubert-Bitter, Self-Controlled Case Series and Misclassification Bias Induced by Case Selection From Administrative Hospital Databases: Application to Febrile Convulsions in Pediatric Vaccine Pharmacoepidemiology, American Journal of Epidemiology, 2013, 178, 12, 1731

    CrossRef

  29. 29
    Donald A. Redelmeier, The exposure-crossover design is a new method for studying sustained changes in recurrent events, Journal of Clinical Epidemiology, 2013, 66, 9, 955

    CrossRef

  30. 30
    Paddy Farrington, Heather Whitaker, Mortality and the self-controlled case series method: Letter to the Editor, Pharmacoepidemiology and Drug Safety, 2012, 21, 8
  31. 31
    Marc Suling, Iris Pigeot, Signal Detection and Monitoring Based on Longitudinal Healthcare Data, Pharmaceutics, 2012, 4, 4, 607

    CrossRef

  32. You have free access to this content32
    Richard Platt, Ryan M. Carnahan, Jeffrey S. Brown, Elizabeth Chrischilles, Lesley H. Curtis, Sean Hennessy, Jennifer C. Nelson, Judith A. Racoosin, Melissa Robb, Sebastian Schneeweiss, Sengwee Toh, Mark G. Weiner, The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction, Pharmacoepidemiology and Drug Safety, 2012, 21,
  33. 33
    Ryan M. Carnahan, Carlos J. Bell, Richard Platt, Active Surveillance: The United States Food and Drug Administration's Sentinel Initiative,